Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-06

FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approves a supplemental application for ABSORICA LD (isotretinoin) filed by Sun Pharmaceutical Industries, resulting in updated labeling for the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABSORICA LD (isotretinoin)

Snippet

SUPPL AP for ABSORICA LD (ISOTRETINOIN)